Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Text Size
6131 studies found for:    "Kidney Diseases"

Modify this search | How to Use Search Results

Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Cancel
Rank Status Study
1 Active, not recruiting Efficacy and Safety of Tolvaptan in Subjects With Chronic Kidney Disease Between Late Stage 2 to Early Stage 4 Due to Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan (OPC-41061);   Drug: Placebo
2 Completed New Quantitive MRI Parameters in Assessing Kidneys of Autosomal Dominant Polycystic Kidney Disease
Conditions: Autosomal Dominant Polycystic Kidney Disease;   Kidney Disease
Intervention:
3 Completed Effect of N-acetylcysteine (NAC) on Hydrogen Sulfide (H2S) in Chronic Kidney Disease (CKD)
Conditions: Chronic Kidney Disease;   Chronic Kidney Failure;   End Stage Kidney Disease;   End Stage Renal Disease
Intervention: Drug: N-acetylcysteine
4 Enrolling by invitation Mechanisms of Diabetic Nephropathy in Ecuador
Conditions: Diabetic Nephropathy;   Diabetes Mellitus;   Kidney Diseases;   Diabetic Kidney Disease;   Chronic Kidney Disease
Intervention:
5 Completed
Has Results 		Randomized Controlled Trial of Vitamin D3 in Diabetic Kidney Disease
Conditions: Diabetes Mellitus;   Chronic Kidney Disease;   Diabetic Kidney Disease
Interventions: Dietary Supplement: Cholecalciferol;   Dietary Supplement: Placebo
6 Completed
Has Results 		ADVANCE: Study to Evaluate Cinacalcet Plus Low Dose Vitamin D on Vascular Calcification in Subjects With Chronic Kidney Disease Receiving Hemodialysis
Conditions: Chronic Kidney Disease;   End Stage Renal Disease;   Coronary Artery Calcification;   Vascular Calcification;   Calcification;   Cardiovascular Disease;   Chronic Renal Failure;   Hyperparathyroidism;   Kidney Disease;   Nephrology;   Secondary Hyperparathyroidism
Intervention: Drug: cinacalcet
7 Completed Pilot Study of RNA as a Biomarker for Autosomal Dominant Polycystic Kidney Disease
Conditions: Chronic Kidney Disease;   Polycystic Kidney, Autosomal Dominant
Intervention:
8 Withdrawn Repository Study of Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
9 Completed 8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
Condition: Autosomal Dominant Polycystic Kidney Disease
Interventions: Drug: Tolvaptan MR;   Drug: Tolvaptan IR;   Drug: Placebo
10 Recruiting Pilot Study of Niacinamide in Polycystic Kidney Disease (NIAC-PKD2)
Condition: Polycystic Kidney Disease
Interventions: Dietary Supplement: Niacinamide;   Other: Placebo
11 Withdrawn Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects
Conditions: Chronic Kidney Disease;   Kidney Disease
Interventions: Drug: MK-0677;   Drug: Placebo
12 Terminated A Study in Participants With Diabetic Kidney Disease
Conditions: Diabetic Kidney Disease;   Diabetic Nephropathy;   Diabetic Glomerulosclerosis
Interventions: Drug: LY2382770;   Drug: Placebo
13 Completed Mesenchymal Stem Cells Transplantation in Patients With Chronic Renal Failure Due to Polycystic Kidney Disease
Conditions: Chronic Renal Failure;   Polycystic Kidney Disease
Intervention: Biological: Intravenous injection autologous mesenchymal stem cells
14 Recruiting Lanreotide In Polycystic Kidney Disease Study
Condition: Autosomal Dominant Polycystic Kidney Disease (ADPKD
Interventions: Drug: Lanreotide;   Drug: saline
15 Not yet recruiting Shear Wave Elastography in Native Kidney Disease
Conditions: Acute Kidney Disease;   Chronic Kidney Disease
Intervention: Other: Shear wave elastography
16 Completed Study to Assess Darbepoetin Alfa in Subjects With Chronic Kidney Disease
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: darbepoetin alfa SF
17 Enrolling by invitation Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention:
18 Completed Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease
Condition: Autosomal Dominant Polycystic Kidney Disease
Intervention: Drug: Tetracosactin
19 Completed Study Evaluating Darbepoetin Alfa in Subjects With Chronic Kidney Disease (CKD) Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Darbepoetin Alfa
20 Completed Cinacalcet HCl in Chronic Kidney Disease Subjects With Secondary Hyperparathyroidism Not Receiving Dialysis
Conditions: Kidney Disease;   Chronic Kidney Disease
Intervention: Drug: Cinacalcet HCl
To Top

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
† Indicates status has not been verified in more than two years